Enliven Therapeutics (ELVN) Earnings Date & Reports
A.I. Advisor
published Earnings
ELVN is expected to report earnings to rise 30.90% to -53 cents per share on November 07
Q3'24
Est.
$-0.54
Q2'24
Beat
by $0.14
Q1'24
Est.
$-0.54
Q1'23
Missed
by $0.17
Q4'22
Beat
by $2.00
The last earnings report on August 13 showed earnings per share of -40 cents, beating the estimate of -55 cents. With 226.70K shares outstanding, the current market capitalization sits at 1.14B.